David B. Samadi

From WikiMD's WELLNESSPEDIA


David B. Samadi (born March 1, 1964) is an American urologist and surgeon known for his expertise in robotic surgery and the treatment of prostate cancer. He is a board-certified urologist and a fellow of the American College of Surgeons.

Early Life and Education[edit]

David B. Samadi was born in Iran and immigrated to the United States at a young age. He completed his undergraduate studies at Stony Brook University, where he earned a degree in biochemistry. He then attended the SUNY Stony Brook School of Medicine, where he received his MD degree.

Medical Career[edit]

Dr. Samadi completed his postgraduate training in urology at Montefiore Medical Center and in oncology at Albert Einstein College of Medicine. He further specialized in laparoscopic surgery at Henri Mondor Hospital in France.

He is renowned for developing the SMART (Samadi Modified Advanced Robotic Technique) for robotic prostate surgery, which has been used to treat thousands of patients with prostate cancer.

Professional Affiliations[edit]

Dr. Samadi is affiliated with several prestigious medical organizations, including the American Urological Association and the American Medical Association. He has also served as the Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center in New York City.

Media Appearances[edit]

Dr. Samadi is a frequent contributor to various media outlets, providing expert commentary on health and medical issues. He has appeared on Fox News, CNN, and other networks to discuss topics related to men's health and prostate cancer.

Personal Life[edit]

David B. Samadi is married and has two children. He is actively involved in community service and philanthropy, supporting various health-related causes.

See Also[edit]

References[edit]

External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=David_B._Samadi&oldid=6618739"